Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Stephen John Eves Evans has worked on the following 17 EPO patent applications which have been published in the last five years:

EP11717011

IMMUNOGENIC PROTEINS AND COMPOSITIONS

IPC classification:
A61K 39/09, C07K 14/315
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11188902

Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use

IPC classification:
C12N 1/20, C12P 21/02
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11758029

BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES

IPC classification:
A61K 39/095, G01N 33/569
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline S.A.
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12709382

COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT

IPC classification:
A61K 31/4375, A61K 31/66, A61K 33/06, A61K 33/08, A61K 33/42, A61K 39/00, A61K 39/095, A61K 39/13, A61K 39/295, A61K 39/39
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12781365

FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

IPC classification:
A61K 39/05
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13705791

PILUS PROTEINS AND COMPOSITIONS

IPC classification:
C07K 1/00
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15151845

Fermentation processes for cultivating streptococci and purification processes for obtaining CPS therefrom

IPC classification:
A61K 39/00, C12N 1/20, C12P 19/04, C12Q 3/00
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13766496

OUTER MEMBRANE VESICLES

IPC classification:
A61K 39/00
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13802107

CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

IPC classification:
A61K 39/08, A61K 39/40, A61P 31/04, C07K 14/33, C07K 16/12, C12N 15/31
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13792601

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/09
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13795176

IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/05, A61K 39/08, A61K 39/09, A61K 39/13
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP14167449

Polysaccharides produced by CPSC mutants

IPC classification:
A61K 39/09, C07K 14/315, C08B 37/00, C12P 19/04
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION REFUSED
EP15193267

HYBRID POLYPEPTIDES INCLUDING MENINGOCOCCAL FHBP SEQUENCES

IPC classification:
A61K 39/095, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11764862

GENERIC ASSAYS FOR DETECTION OF MAMMALIAN REOVIRUS

IPC classification:
C12Q 1/70
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15707351

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

IPC classification:
A61K 39/095, C07K 14/095, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION REQUESTED
EP15720977

PURIFICATION OF SECRETED POLYSACCHARIDES FROM S. AGALACTIAE

IPC classification:
A61K 39/09, C07K 14/315, C08B 37/00, C12P 19/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15744610

CARRIER MOLECULE FOR ANTIGENS

IPC classification:
A61P 37/04, A61K 47/50
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature